 |
|
Yellow FeverA Decade of Reemergence
Susan E. Robertson, MD, MPH, MS;
Barbara P. Hull, PhD;
Oyewale Tomori, PhD;
Okwo Bele, MD, MPH;
James W. LeDuc, PhD;
Karin Esteves
JAMA. 1996;276(14):1157-1162.
Abstract
| |
Since the 1980s, yellow fever has reemerged across Africa and in South America. The total of 18 735 yellow fever cases and 4522 deaths reported from 1987 to 1991 represents the greatest amount of yellow fever activity reported to the World Health Organization (WHO) for any 5-year period since 1948. There is an excellent vaccine against yellow fever. At present, a high proportion of travelers to at-risk areas are reported to be immunized, reflecting widespread knowledge about the International Health Regulations. In South America, yellow fever remains an occupational hazard for forest workers, who should be immunized. However, Aedes aegypti mosquitoes are now present in urban areas in the Americas (including southern parts of the United States), and there is concern that yellow fever could erupt in explosive outbreaks. In Africa, a large proportion of cases have occurred in children. The WHO, the United Nations Children's Fund (UNICEF), and the World Bank have recommended that 33 African countries at risk for yellow fever add the vaccine to the routine Expanded Programme on Immunization; studies show that this would be highly cost-effective. To date, financing yellow fever vaccine has been a major problem for these countries, which are among the poorest in the world. For this reason, WHO has launched an appeal to raise $70 million for yellow fever control in Africa.
Author Affiliations
From the Global Programme for Vaccines and Immunization, World Health Organization (WHO), Geneva, Switzerland (Drs Robertson and Hull); the Expanded Programme on Immunization, WHO Regional Office for Africa, Brazzaville, Congo (Drs Tomori and Bele); and the Division of Emerging and Other Communicable Diseases Surveillance and Control, WHO, Geneva (Dr LeDuc and Ms Esteves).
Footnotes
Reprints: Susan E. Robertson, MD, MPH, MS, Global Programme for Vaccines and Immunization, World Health Organization, 1211 Geneva 27, Switzerland (e-mail: robertsons@who.ch).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Flavivirus Infection Activates the XBP1 Pathway of the Unfolded Protein Response To Cope with Endoplasmic Reticulum Stress
Yu et al.
J. Virol. 2006;80:11868-11880.
ABSTRACT
| FULL TEXT
Genome analysis and phylogenetic relationships between east, central and west African isolates of Yellow fever virus.
von Lindern et al.
J. Gen. Virol. 2006;87:895-907.
ABSTRACT
| FULL TEXT
Characterization of an infectious clone of the wild-type yellow fever virus Asibi strain that is able to infect and disseminate in mosquitoes
McElroy et al.
J. Gen. Virol. 2005;86:1747-1751.
ABSTRACT
| FULL TEXT
RANDOMIZED, DOUBLE-BLIND, PHASE III, PIVOTAL FIELD TRIAL OF THE COMPARATIVE IMMUNOGENICITY, SAFETY, AND TOLERABILITY OF TWO YELLOW FEVER 17D VACCINES (ARILVAXTM AND YF-VAX(R)) IN HEALTHY INFANTS AND CHILDREN IN PERU
BELMUSTO-WORN et al.
Am J Trop Med Hyg 2005;72:189-197.
ABSTRACT
| FULL TEXT
EFFICACY OF POST-EXPOSURE TREATMENT OF YELLOW FEVER WITH RIBAVIRIN IN A HAMSTER MODEL OF THE DISEASE
SBRANA et al.
Am J Trop Med Hyg 2004;71:306-312.
ABSTRACT
| FULL TEXT
LARGE GENETIC DIFFERENTIATION AND LOW VARIATION IN VECTOR COMPETENCE FOR DENGUE AND YELLOW FEVER VIRUSES OF AEDES ALBOPICTUS FROM BRAZIL, THE UNITED STATES, AND THE CAYMAN ISLANDS
DE OLIVEIRA et al.
Am J Trop Med Hyg 2003;69:105-114.
ABSTRACT
| FULL TEXT
Molecular Characterization of a Hamster Viscerotropic Strain of Yellow Fever Virus
McArthur et al.
J. Virol. 2002;77:1462-1468.
ABSTRACT
| FULL TEXT
Antiviral Effects of an Iminosugar Derivative on Flavivirus Infections
Wu et al.
J. Virol. 2002;76:3596-3604.
ABSTRACT
| FULL TEXT
Phylogenetic and Evolutionary Relationships among Yellow Fever Virus Isolates in Africa
Mutebi et al.
J. Virol. 2001;75:6999-7008.
ABSTRACT
| FULL TEXT
Fatal Yellow Fever in a Traveler Returning From Venezuela, 1999
JAMA 2000;283:2230-2232.
FULL TEXT
Viral Disease in Hematology
Franchini et al.
ASH Education Book 2000;2000:409-423.
ABSTRACT
| FULL TEXT
Inhibition of luciferase expression in transgenic Aedes aegypti mosquitoes by Sindbis virus expression of antisense luciferase RNA
Johnson et al.
Proc. Natl. Acad. Sci. USA 1999;96:13399-13403.
ABSTRACT
| FULL TEXT
An important step forward in the genetic manipulation of mosquito vectors of human disease
Kidwell and Wattam
Proc. Natl. Acad. Sci. USA 1998;95:3349-3350.
FULL TEXT
|
